Literature DB >> 3729988

Properties of a folate binding protein (FBP) isolated from porcine kidney.

B A Kamen, J D Caston.   

Abstract

A specific high-affinity folate binding protein (FBP) that binds folic acid and folic acid derivatives and that was previously identified in porcine kidney has been purified 50,000-fold using the technique of affinity chromatography. The FBP had a molecular weight of 38,500 daltons and did not appear to aggregate in solution, as has been reported to be the case with folate binding protein from milk. At pH 7.6, the Ka was at least 5 X 10(12)M-1. At pH values greater than 9.5 or less than 5, the binding dramatically decreased. The specificity was determined by an isotopic dilution technique using [3H]folic acid and folic acid analogs and derivatives. The FBP reacted more rapidly with unsubstituted folates, and the number of glutamic acid moieties (N greater than or equal to 1) did not influence binding. Binding of folic acid to the FBP was unaffected by a variety of anions and cations, and 8 M urea, but was disrupted by 6 M guanidine hydrochloride. Proteolytic enzymes irreversibly destroyed binding affinity, but RNase, DNase, phospholipase and neuraminidase had no effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729988     DOI: 10.1016/0006-2952(86)90458-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor.

Authors:  Antonio Quintana; Ewa Raczka; Lars Piehler; Inhan Lee; Andrzej Myc; Istvan Majoros; Anil K Patri; Thommey Thomas; James Mulé; James R Baker
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

2.  Folate binding protein: molecular characterization and transcript distribution in pig liver, kidney and jejunum.

Authors:  C M Van Hoozen; E H Ling; C H Halsted
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

3.  Growth-inhibitory effects of 5,10-dideazatetrahydrofolic acid on variant murine L1210 and human CCRF-CEM leukemia cells with different membrane-transport characteristics for (anti)folate compounds.

Authors:  G Jansen; G R Westerhof; I Kathmann; G Rijksen; J H Schornagel
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Plasma methotrexate, red blood cell methotrexate, and red blood cell folate values and outcome in children with precursor B-acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Naomi J Winick; Pierre Wacker; Xiaomin Lu; Meenakshi Devidas; Jonathan J Shuster; Donald H Mahoney; Stephen J Lauer; Bruce M Camitta
Journal:  J Pediatr Hematol Oncol       Date:  2012-01       Impact factor: 1.289

5.  Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.

Authors:  Sherine Abdelmawla; Songchuan Guo; Limin Zhang; Sai M Pulukuri; Prithviraj Patankar; Patrick Conley; Joseph Trebley; Peixuan Guo; Qi-Xiang Li
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

6.  Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study.

Authors:  M L Graham; J J Shuster; B A Kamen; D L Cheo; M P Harrison; B G Leventhal; D J Pullen; V M Whitehead
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 7.  Folate action in nervous system development and disease.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Dev Neurobiol       Date:  2018-02-06       Impact factor: 3.964

8.  The folate receptor in central nervous system malignancies of childhood.

Authors:  S D Weitman; K M Frazier; B A Kamen
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Interaction of cancer cells with magnetic nanoparticles modified by methacrylamido-folic acid.

Authors:  Nagehan Saltan; H Mehtap Kutlu; Deniz Hür; Arzu Işcan; Ridvan Say
Journal:  Int J Nanomedicine       Date:  2011-02-28

10.  Surface-enhanced Raman scattering investigation of targeted delivery and controlled release of gemcitabine.

Authors:  Ty Santiago; Rebecca Sinnott DeVaux; Katarzyna Kurzatkowska; Ricardo Espinal; Jason I Herschkowitz; Maria Hepel
Journal:  Int J Nanomedicine       Date:  2017-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.